FDA.reportPublic FDA data

Application 209013

Type
ANDA
Sponsor
UPSHER SMITH LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DOXAZOSIN MESYLATEDOXAZOSIN MESYLATETABLET;ORALEQ 1MG BASENoNo
002DOXAZOSIN MESYLATEDOXAZOSIN MESYLATETABLET;ORALEQ 2MG BASENoNo
003DOXAZOSIN MESYLATEDOXAZOSIN MESYLATETABLET;ORALEQ 4MG BASENoNo
004DOXAZOSIN MESYLATEDOXAZOSIN MESYLATETABLET;ORALEQ 8MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0832-0356DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-0356DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-0356DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-0357DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-0357DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-0357DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-1358DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-1358DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-1358DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-1359DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-1359DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
0832-1359DoxazosinDoxazosin MesylateUpsher-Smith laboratories, LLCANDACurrent
50090-6298DoxazosinDoxazosin MesylateA-S Medication SolutionsANDACurrent
71610-420DoxazosinDoxazosin MesylateAphena Pharma Solutions - Tennessee, LLCANDACurrent
71610-420DoxazosinDoxazosin MesylateAphena Pharma Solutions - Tennessee, LLCANDACurrent
71610-482DoxazosinDoxazosin MesylateAphena Pharma Solutions - Tennessee, LLCANDACurrent